Sort   by:  
 Page size 
UnknownBacillus thuringiensis Cry5, Cry21, App6 and Xpp55 proteins to control Meloidogyne javanica and M. incognita.
Not available
S-EPMC11614921 | biostudies-literature
UnknownMulticenter clinical evaluation of a novel transcription-mediated amplification assay for SARS-CoV-2 molecular testing.
Not available
S-EPMC10107077 | biostudies-literature
TranscriptomicsRegulatory T cell modulation by CBP/EP300 bromodomain inhibition [array]
Genome-wide gene expression changes in response to CBP inhibitor treatment in Treg cells using microarray. Expression profiling by microarray of Treg cells treated with DMSO or CBP inhibitor, and Th0 cells
ORGANISM(S): Homo sapiens 
2016-07-06 | E-GEOD-66596 | biostudies-arrayexpress
TranscriptomicsBET bromodomain inhibition suppresses TH17-mediated pathology
IL-17-producing T helper (TH17) cells have been selected through evolution for their ability to control fungal and bacterial infections. It is also firmly established that their aberrant generation and activation results in autoimmune conditions. Using a characterized potent and selective small mole...
ORGANISM(S): Mus musculus 
2013-09-20 | E-GEOD-37270 | biostudies-arrayexpress
Unknown
Not available
S-EPMC8841142 | biostudies-literature
UnknownBurkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma.
Not available
S-EPMC6717587 | biostudies-literature
GenomicsRegulatory T cell modulation by CBP/EP300 bromodomain inhibition [ChIP-seq]
Genome-wide chromatin H3K27ac, H3K18ac and H3K4me3 occupancy changes in response to CBP inhibitor treatment in Treg cells using ChIP sequencing (ChIP-seq). Expression profiling by ChIP-seq of Treg cells treated with DMSO or CBP inhibitor
ORGANISM(S): Homo sapiens 
2016-04-06 | E-GEOD-70708 | biostudies-arrayexpress
UnknownMYC-rearranged mature B-cell lymphomas in children and young adults are molecularly Burkitt Lymphoma.
Not available
S-EPMC11458770 | biostudies-literature
TranscriptomicsRegulatory T cell modulation by CBP/EP300 bromodomain inhibition [RNA-seq]
Genome-wide gene expression changes in response to CBP inhibitor treatment in Treg cells using RNA sequencing (RNA-seq). Expression profiling by RNA-seq of Treg cells treated with DMSO or CBP inhibitor
ORGANISM(S): Homo sapiens 
2016-04-06 | E-GEOD-70620 | biostudies-arrayexpress
UnknownSubcutaneous anti-COVID-19 hyperimmune immunoglobulin for prevention of disease in asymptomatic individuals with SARS-CoV-2 infection: a double-blind, placebo-controlled, randomised clinical trial.
Not available
S-EPMC10005687 | biostudies-literature
Sort   by:  
 Page size